Global Pharmaceutical CDMO and Contract Manufacturing Services Supply, Demand and Key Producers, 2023-2029
The global Pharmaceutical CDMO and Contract Manufacturing Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
In order to reduce drug R&D costs and improve production efficiency, pharmaceutical company customers entrust pharmaceutical process R&D and production to customized companies. The company accepts the entrustment of multinational pharmaceutical companies to provide pharmaceutical process research and development and drug production services, which are CDMO services.
This report studies the global Pharmaceutical CDMO and Contract Manufacturing Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO and Contract Manufacturing Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO and Contract Manufacturing Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO and Contract Manufacturing Services total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO and Contract Manufacturing Services total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Pharmaceutical CDMO and Contract Manufacturing Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical and Hetero, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO and Contract Manufacturing Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO and Contract Manufacturing Services Market, By Region:
1. How big is the global Pharmaceutical CDMO and Contract Manufacturing Services market?
2. What is the demand of the global Pharmaceutical CDMO and Contract Manufacturing Services market?
3. What is the year over year growth of the global Pharmaceutical CDMO and Contract Manufacturing Services market?
4. What is the total value of the global Pharmaceutical CDMO and Contract Manufacturing Services market?
5. Who are the major players in the global Pharmaceutical CDMO and Contract Manufacturing Services market?
In order to reduce drug R&D costs and improve production efficiency, pharmaceutical company customers entrust pharmaceutical process R&D and production to customized companies. The company accepts the entrustment of multinational pharmaceutical companies to provide pharmaceutical process research and development and drug production services, which are CDMO services.
This report studies the global Pharmaceutical CDMO and Contract Manufacturing Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO and Contract Manufacturing Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO and Contract Manufacturing Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO and Contract Manufacturing Services total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO and Contract Manufacturing Services total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO and Contract Manufacturing Services total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Pharmaceutical CDMO and Contract Manufacturing Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical and Hetero, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO and Contract Manufacturing Services market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO and Contract Manufacturing Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Drug Development
- API production
- Pharma Industry
- Biotechnology
- Others
- Haixiang Pharmaceutical
- Innovent Biologics
- Betta Pharmaceuticals
- Jiuzhou Pharmaceutical
- Puluo Pharmaceutical
- Menohua
- Tianyu shares
- Aoxiang Pharmaceutical
- Hetero
- CellMark
- R&D Systems
- Porton Pharmaceuticals
- Kai Laiying
- Smart Life
- Notai Biotech
- Aurobindo Pharma
- Lonza Group
- Catalent Inc.
- Recipharm AB
- Jubilant Pharmova Ltd
- Patheon Inc. (Thermo Fisher Scientific Inc.)
- Boehringer Ingelheim Group
- Pfizer CentreSource
- Baxter International Inc.
- Lonza Group
1. How big is the global Pharmaceutical CDMO and Contract Manufacturing Services market?
2. What is the demand of the global Pharmaceutical CDMO and Contract Manufacturing Services market?
3. What is the year over year growth of the global Pharmaceutical CDMO and Contract Manufacturing Services market?
4. What is the total value of the global Pharmaceutical CDMO and Contract Manufacturing Services market?
5. Who are the major players in the global Pharmaceutical CDMO and Contract Manufacturing Services market?
1 SUPPLY SUMMARY
1.1 Pharmaceutical CDMO and Contract Manufacturing Services Introduction
1.2 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO and Contract Manufacturing Services Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO and Contract Manufacturing Services Major Market Trends
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value by Region
2.2.1 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO and Contract Manufacturing Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO and Contract Manufacturing Services in 2022
3.3 Pharmaceutical CDMO and Contract Manufacturing Services Company Evaluation Quadrant
3.4 Pharmaceutical CDMO and Contract Manufacturing Services Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market: Region Footprint
3.4.2 Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO and Contract Manufacturing Services Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO and Contract Manufacturing Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Drug Development
5.2.2 API production
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharma Industry
6.2.2 Biotechnology
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Haixiang Pharmaceutical
7.1.1 Haixiang Pharmaceutical Details
7.1.2 Haixiang Pharmaceutical Major Business
7.1.3 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.1.4 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Haixiang Pharmaceutical Recent Developments/Updates
7.1.6 Haixiang Pharmaceutical Competitive Strengths & Weaknesses
7.2 Innovent Biologics
7.2.1 Innovent Biologics Details
7.2.2 Innovent Biologics Major Business
7.2.3 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.2.4 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Innovent Biologics Recent Developments/Updates
7.2.6 Innovent Biologics Competitive Strengths & Weaknesses
7.3 Betta Pharmaceuticals
7.3.1 Betta Pharmaceuticals Details
7.3.2 Betta Pharmaceuticals Major Business
7.3.3 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.3.4 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Betta Pharmaceuticals Recent Developments/Updates
7.3.6 Betta Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Jiuzhou Pharmaceutical
7.4.1 Jiuzhou Pharmaceutical Details
7.4.2 Jiuzhou Pharmaceutical Major Business
7.4.3 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.4.4 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Jiuzhou Pharmaceutical Recent Developments/Updates
7.4.6 Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
7.5 Puluo Pharmaceutical
7.5.1 Puluo Pharmaceutical Details
7.5.2 Puluo Pharmaceutical Major Business
7.5.3 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.5.4 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Puluo Pharmaceutical Recent Developments/Updates
7.5.6 Puluo Pharmaceutical Competitive Strengths & Weaknesses
7.6 Menohua
7.6.1 Menohua Details
7.6.2 Menohua Major Business
7.6.3 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.6.4 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Menohua Recent Developments/Updates
7.6.6 Menohua Competitive Strengths & Weaknesses
7.7 Tianyu shares
7.7.1 Tianyu shares Details
7.7.2 Tianyu shares Major Business
7.7.3 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.7.4 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Tianyu shares Recent Developments/Updates
7.7.6 Tianyu shares Competitive Strengths & Weaknesses
7.8 Aoxiang Pharmaceutical
7.8.1 Aoxiang Pharmaceutical Details
7.8.2 Aoxiang Pharmaceutical Major Business
7.8.3 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.8.4 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Aoxiang Pharmaceutical Recent Developments/Updates
7.8.6 Aoxiang Pharmaceutical Competitive Strengths & Weaknesses
7.9 Hetero
7.9.1 Hetero Details
7.9.2 Hetero Major Business
7.9.3 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.9.4 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Hetero Recent Developments/Updates
7.9.6 Hetero Competitive Strengths & Weaknesses
7.10 CellMark
7.10.1 CellMark Details
7.10.2 CellMark Major Business
7.10.3 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.10.4 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CellMark Recent Developments/Updates
7.10.6 CellMark Competitive Strengths & Weaknesses
7.11 R&D Systems
7.11.1 R&D Systems Details
7.11.2 R&D Systems Major Business
7.11.3 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.11.4 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 R&D Systems Recent Developments/Updates
7.11.6 R&D Systems Competitive Strengths & Weaknesses
7.12 Porton Pharmaceuticals
7.12.1 Porton Pharmaceuticals Details
7.12.2 Porton Pharmaceuticals Major Business
7.12.3 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.12.4 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Porton Pharmaceuticals Recent Developments/Updates
7.12.6 Porton Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Kai Laiying
7.13.1 Kai Laiying Details
7.13.2 Kai Laiying Major Business
7.13.3 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.13.4 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Kai Laiying Recent Developments/Updates
7.13.6 Kai Laiying Competitive Strengths & Weaknesses
7.14 Smart Life
7.14.1 Smart Life Details
7.14.2 Smart Life Major Business
7.14.3 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.14.4 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Smart Life Recent Developments/Updates
7.14.6 Smart Life Competitive Strengths & Weaknesses
7.15 Notai Biotech
7.15.1 Notai Biotech Details
7.15.2 Notai Biotech Major Business
7.15.3 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.15.4 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Notai Biotech Recent Developments/Updates
7.15.6 Notai Biotech Competitive Strengths & Weaknesses
7.16 Aurobindo Pharma
7.16.1 Aurobindo Pharma Details
7.16.2 Aurobindo Pharma Major Business
7.16.3 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.16.4 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Aurobindo Pharma Recent Developments/Updates
7.16.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.17 Lonza Group
7.17.1 Lonza Group Details
7.17.2 Lonza Group Major Business
7.17.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.17.4 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Lonza Group Recent Developments/Updates
7.17.6 Lonza Group Competitive Strengths & Weaknesses
7.18 Catalent Inc.
7.18.1 Catalent Inc. Details
7.18.2 Catalent Inc. Major Business
7.18.3 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.18.4 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Catalent Inc. Recent Developments/Updates
7.18.6 Catalent Inc. Competitive Strengths & Weaknesses
7.19 Recipharm AB
7.19.1 Recipharm AB Details
7.19.2 Recipharm AB Major Business
7.19.3 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.19.4 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Recipharm AB Recent Developments/Updates
7.19.6 Recipharm AB Competitive Strengths & Weaknesses
7.20 Jubilant Pharmova Ltd
7.20.1 Jubilant Pharmova Ltd Details
7.20.2 Jubilant Pharmova Ltd Major Business
7.20.3 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.20.4 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Jubilant Pharmova Ltd Recent Developments/Updates
7.20.6 Jubilant Pharmova Ltd Competitive Strengths & Weaknesses
7.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
7.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Details
7.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Major Business
7.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Developments/Updates
7.21.6 Patheon Inc. (Thermo Fisher Scientific Inc.) Competitive Strengths & Weaknesses
7.22 Boehringer Ingelheim Group
7.22.1 Boehringer Ingelheim Group Details
7.22.2 Boehringer Ingelheim Group Major Business
7.22.3 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.22.4 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Boehringer Ingelheim Group Recent Developments/Updates
7.22.6 Boehringer Ingelheim Group Competitive Strengths & Weaknesses
7.23 Pfizer CentreSource
7.23.1 Pfizer CentreSource Details
7.23.2 Pfizer CentreSource Major Business
7.23.3 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.23.4 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Pfizer CentreSource Recent Developments/Updates
7.23.6 Pfizer CentreSource Competitive Strengths & Weaknesses
7.24 Baxter International Inc.
7.24.1 Baxter International Inc. Details
7.24.2 Baxter International Inc. Major Business
7.24.3 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.24.4 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Baxter International Inc. Recent Developments/Updates
7.24.6 Baxter International Inc. Competitive Strengths & Weaknesses
7.25 Lonza Group
7.25.1 Lonza Group Details
7.25.2 Lonza Group Major Business
7.25.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.25.4 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Lonza Group Recent Developments/Updates
7.25.6 Lonza Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical CDMO and Contract Manufacturing Services Industry Chain
8.2 Pharmaceutical CDMO and Contract Manufacturing Services Upstream Analysis
8.3 Pharmaceutical CDMO and Contract Manufacturing Services Midstream Analysis
8.4 Pharmaceutical CDMO and Contract Manufacturing Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pharmaceutical CDMO and Contract Manufacturing Services Introduction
1.2 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO and Contract Manufacturing Services Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO and Contract Manufacturing Services Major Market Trends
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value by Region
2.2.1 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO and Contract Manufacturing Services in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO and Contract Manufacturing Services in 2022
3.3 Pharmaceutical CDMO and Contract Manufacturing Services Company Evaluation Quadrant
3.4 Pharmaceutical CDMO and Contract Manufacturing Services Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market: Region Footprint
3.4.2 Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO and Contract Manufacturing Services Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO and Contract Manufacturing Services Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Drug Development
5.2.2 API production
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharma Industry
6.2.2 Biotechnology
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Haixiang Pharmaceutical
7.1.1 Haixiang Pharmaceutical Details
7.1.2 Haixiang Pharmaceutical Major Business
7.1.3 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.1.4 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Haixiang Pharmaceutical Recent Developments/Updates
7.1.6 Haixiang Pharmaceutical Competitive Strengths & Weaknesses
7.2 Innovent Biologics
7.2.1 Innovent Biologics Details
7.2.2 Innovent Biologics Major Business
7.2.3 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.2.4 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Innovent Biologics Recent Developments/Updates
7.2.6 Innovent Biologics Competitive Strengths & Weaknesses
7.3 Betta Pharmaceuticals
7.3.1 Betta Pharmaceuticals Details
7.3.2 Betta Pharmaceuticals Major Business
7.3.3 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.3.4 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Betta Pharmaceuticals Recent Developments/Updates
7.3.6 Betta Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Jiuzhou Pharmaceutical
7.4.1 Jiuzhou Pharmaceutical Details
7.4.2 Jiuzhou Pharmaceutical Major Business
7.4.3 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.4.4 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Jiuzhou Pharmaceutical Recent Developments/Updates
7.4.6 Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
7.5 Puluo Pharmaceutical
7.5.1 Puluo Pharmaceutical Details
7.5.2 Puluo Pharmaceutical Major Business
7.5.3 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.5.4 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Puluo Pharmaceutical Recent Developments/Updates
7.5.6 Puluo Pharmaceutical Competitive Strengths & Weaknesses
7.6 Menohua
7.6.1 Menohua Details
7.6.2 Menohua Major Business
7.6.3 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.6.4 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Menohua Recent Developments/Updates
7.6.6 Menohua Competitive Strengths & Weaknesses
7.7 Tianyu shares
7.7.1 Tianyu shares Details
7.7.2 Tianyu shares Major Business
7.7.3 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.7.4 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Tianyu shares Recent Developments/Updates
7.7.6 Tianyu shares Competitive Strengths & Weaknesses
7.8 Aoxiang Pharmaceutical
7.8.1 Aoxiang Pharmaceutical Details
7.8.2 Aoxiang Pharmaceutical Major Business
7.8.3 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.8.4 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Aoxiang Pharmaceutical Recent Developments/Updates
7.8.6 Aoxiang Pharmaceutical Competitive Strengths & Weaknesses
7.9 Hetero
7.9.1 Hetero Details
7.9.2 Hetero Major Business
7.9.3 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.9.4 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Hetero Recent Developments/Updates
7.9.6 Hetero Competitive Strengths & Weaknesses
7.10 CellMark
7.10.1 CellMark Details
7.10.2 CellMark Major Business
7.10.3 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.10.4 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CellMark Recent Developments/Updates
7.10.6 CellMark Competitive Strengths & Weaknesses
7.11 R&D Systems
7.11.1 R&D Systems Details
7.11.2 R&D Systems Major Business
7.11.3 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.11.4 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 R&D Systems Recent Developments/Updates
7.11.6 R&D Systems Competitive Strengths & Weaknesses
7.12 Porton Pharmaceuticals
7.12.1 Porton Pharmaceuticals Details
7.12.2 Porton Pharmaceuticals Major Business
7.12.3 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.12.4 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Porton Pharmaceuticals Recent Developments/Updates
7.12.6 Porton Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Kai Laiying
7.13.1 Kai Laiying Details
7.13.2 Kai Laiying Major Business
7.13.3 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.13.4 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Kai Laiying Recent Developments/Updates
7.13.6 Kai Laiying Competitive Strengths & Weaknesses
7.14 Smart Life
7.14.1 Smart Life Details
7.14.2 Smart Life Major Business
7.14.3 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.14.4 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Smart Life Recent Developments/Updates
7.14.6 Smart Life Competitive Strengths & Weaknesses
7.15 Notai Biotech
7.15.1 Notai Biotech Details
7.15.2 Notai Biotech Major Business
7.15.3 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.15.4 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Notai Biotech Recent Developments/Updates
7.15.6 Notai Biotech Competitive Strengths & Weaknesses
7.16 Aurobindo Pharma
7.16.1 Aurobindo Pharma Details
7.16.2 Aurobindo Pharma Major Business
7.16.3 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.16.4 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Aurobindo Pharma Recent Developments/Updates
7.16.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.17 Lonza Group
7.17.1 Lonza Group Details
7.17.2 Lonza Group Major Business
7.17.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.17.4 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Lonza Group Recent Developments/Updates
7.17.6 Lonza Group Competitive Strengths & Weaknesses
7.18 Catalent Inc.
7.18.1 Catalent Inc. Details
7.18.2 Catalent Inc. Major Business
7.18.3 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.18.4 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Catalent Inc. Recent Developments/Updates
7.18.6 Catalent Inc. Competitive Strengths & Weaknesses
7.19 Recipharm AB
7.19.1 Recipharm AB Details
7.19.2 Recipharm AB Major Business
7.19.3 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.19.4 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Recipharm AB Recent Developments/Updates
7.19.6 Recipharm AB Competitive Strengths & Weaknesses
7.20 Jubilant Pharmova Ltd
7.20.1 Jubilant Pharmova Ltd Details
7.20.2 Jubilant Pharmova Ltd Major Business
7.20.3 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.20.4 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Jubilant Pharmova Ltd Recent Developments/Updates
7.20.6 Jubilant Pharmova Ltd Competitive Strengths & Weaknesses
7.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
7.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Details
7.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Major Business
7.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Developments/Updates
7.21.6 Patheon Inc. (Thermo Fisher Scientific Inc.) Competitive Strengths & Weaknesses
7.22 Boehringer Ingelheim Group
7.22.1 Boehringer Ingelheim Group Details
7.22.2 Boehringer Ingelheim Group Major Business
7.22.3 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.22.4 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Boehringer Ingelheim Group Recent Developments/Updates
7.22.6 Boehringer Ingelheim Group Competitive Strengths & Weaknesses
7.23 Pfizer CentreSource
7.23.1 Pfizer CentreSource Details
7.23.2 Pfizer CentreSource Major Business
7.23.3 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.23.4 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Pfizer CentreSource Recent Developments/Updates
7.23.6 Pfizer CentreSource Competitive Strengths & Weaknesses
7.24 Baxter International Inc.
7.24.1 Baxter International Inc. Details
7.24.2 Baxter International Inc. Major Business
7.24.3 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.24.4 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Baxter International Inc. Recent Developments/Updates
7.24.6 Baxter International Inc. Competitive Strengths & Weaknesses
7.25 Lonza Group
7.25.1 Lonza Group Details
7.25.2 Lonza Group Major Business
7.25.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
7.25.4 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Lonza Group Recent Developments/Updates
7.25.6 Lonza Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical CDMO and Contract Manufacturing Services Industry Chain
8.2 Pharmaceutical CDMO and Contract Manufacturing Services Upstream Analysis
8.3 Pharmaceutical CDMO and Contract Manufacturing Services Midstream Analysis
8.4 Pharmaceutical CDMO and Contract Manufacturing Services Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO and Contract Manufacturing Services Players in 2022
Table 12. World Pharmaceutical CDMO and Contract Manufacturing Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO and Contract Manufacturing Services Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO and Contract Manufacturing Services Player
Table 15. Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO and Contract Manufacturing Services Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO and Contract Manufacturing Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Haixiang Pharmaceutical Basic Information, Area Served and Competitors
Table 36. Haixiang Pharmaceutical Major Business
Table 37. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 38. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Haixiang Pharmaceutical Recent Developments/Updates
Table 40. Haixiang Pharmaceutical Competitive Strengths & Weaknesses
Table 41. Innovent Biologics Basic Information, Area Served and Competitors
Table 42. Innovent Biologics Major Business
Table 43. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 44. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Innovent Biologics Recent Developments/Updates
Table 46. Innovent Biologics Competitive Strengths & Weaknesses
Table 47. Betta Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Betta Pharmaceuticals Major Business
Table 49. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 50. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Betta Pharmaceuticals Recent Developments/Updates
Table 52. Betta Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Jiuzhou Pharmaceutical Basic Information, Area Served and Competitors
Table 54. Jiuzhou Pharmaceutical Major Business
Table 55. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 56. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Jiuzhou Pharmaceutical Recent Developments/Updates
Table 58. Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 59. Puluo Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Puluo Pharmaceutical Major Business
Table 61. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 62. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Puluo Pharmaceutical Recent Developments/Updates
Table 64. Puluo Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Menohua Basic Information, Area Served and Competitors
Table 66. Menohua Major Business
Table 67. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 68. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Menohua Recent Developments/Updates
Table 70. Menohua Competitive Strengths & Weaknesses
Table 71. Tianyu shares Basic Information, Area Served and Competitors
Table 72. Tianyu shares Major Business
Table 73. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 74. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Tianyu shares Recent Developments/Updates
Table 76. Tianyu shares Competitive Strengths & Weaknesses
Table 77. Aoxiang Pharmaceutical Basic Information, Area Served and Competitors
Table 78. Aoxiang Pharmaceutical Major Business
Table 79. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 80. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Aoxiang Pharmaceutical Recent Developments/Updates
Table 82. Aoxiang Pharmaceutical Competitive Strengths & Weaknesses
Table 83. Hetero Basic Information, Area Served and Competitors
Table 84. Hetero Major Business
Table 85. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 86. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Hetero Recent Developments/Updates
Table 88. Hetero Competitive Strengths & Weaknesses
Table 89. CellMark Basic Information, Area Served and Competitors
Table 90. CellMark Major Business
Table 91. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 92. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CellMark Recent Developments/Updates
Table 94. CellMark Competitive Strengths & Weaknesses
Table 95. R&D Systems Basic Information, Area Served and Competitors
Table 96. R&D Systems Major Business
Table 97. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 98. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. R&D Systems Recent Developments/Updates
Table 100. R&D Systems Competitive Strengths & Weaknesses
Table 101. Porton Pharmaceuticals Basic Information, Area Served and Competitors
Table 102. Porton Pharmaceuticals Major Business
Table 103. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 104. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Porton Pharmaceuticals Recent Developments/Updates
Table 106. Porton Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. Kai Laiying Basic Information, Area Served and Competitors
Table 108. Kai Laiying Major Business
Table 109. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 110. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Kai Laiying Recent Developments/Updates
Table 112. Kai Laiying Competitive Strengths & Weaknesses
Table 113. Smart Life Basic Information, Area Served and Competitors
Table 114. Smart Life Major Business
Table 115. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 116. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Smart Life Recent Developments/Updates
Table 118. Smart Life Competitive Strengths & Weaknesses
Table 119. Notai Biotech Basic Information, Area Served and Competitors
Table 120. Notai Biotech Major Business
Table 121. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 122. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Notai Biotech Recent Developments/Updates
Table 124. Notai Biotech Competitive Strengths & Weaknesses
Table 125. Aurobindo Pharma Basic Information, Area Served and Competitors
Table 126. Aurobindo Pharma Major Business
Table 127. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 128. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 131. Lonza Group Basic Information, Area Served and Competitors
Table 132. Lonza Group Major Business
Table 133. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 134. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Lonza Group Recent Developments/Updates
Table 136. Lonza Group Competitive Strengths & Weaknesses
Table 137. Catalent Inc. Basic Information, Area Served and Competitors
Table 138. Catalent Inc. Major Business
Table 139. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 140. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Catalent Inc. Recent Developments/Updates
Table 142. Catalent Inc. Competitive Strengths & Weaknesses
Table 143. Recipharm AB Basic Information, Area Served and Competitors
Table 144. Recipharm AB Major Business
Table 145. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 146. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Recipharm AB Recent Developments/Updates
Table 148. Recipharm AB Competitive Strengths & Weaknesses
Table 149. Jubilant Pharmova Ltd Basic Information, Area Served and Competitors
Table 150. Jubilant Pharmova Ltd Major Business
Table 151. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 152. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Jubilant Pharmova Ltd Recent Developments/Updates
Table 154. Jubilant Pharmova Ltd Competitive Strengths & Weaknesses
Table 155. Patheon Inc. (Thermo Fisher Scientific Inc.) Basic Information, Area Served and Competitors
Table 156. Patheon Inc. (Thermo Fisher Scientific Inc.) Major Business
Table 157. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 158. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Developments/Updates
Table 160. Patheon Inc. (Thermo Fisher Scientific Inc.) Competitive Strengths & Weaknesses
Table 161. Boehringer Ingelheim Group Basic Information, Area Served and Competitors
Table 162. Boehringer Ingelheim Group Major Business
Table 163. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 164. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Boehringer Ingelheim Group Recent Developments/Updates
Table 166. Boehringer Ingelheim Group Competitive Strengths & Weaknesses
Table 167. Pfizer CentreSource Basic Information, Area Served and Competitors
Table 168. Pfizer CentreSource Major Business
Table 169. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 170. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Pfizer CentreSource Recent Developments/Updates
Table 172. Pfizer CentreSource Competitive Strengths & Weaknesses
Table 173. Baxter International Inc. Basic Information, Area Served and Competitors
Table 174. Baxter International Inc. Major Business
Table 175. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 176. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Baxter International Inc. Recent Developments/Updates
Table 178. Lonza Group Basic Information, Area Served and Competitors
Table 179. Lonza Group Major Business
Table 180. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 181. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 182. Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services Upstream (Raw Materials)
Table 183. Pharmaceutical CDMO and Contract Manufacturing Services Typical Customers
LIST OF FIGURE
Figure 1. Pharmaceutical CDMO and Contract Manufacturing Services Picture
Figure 2. World Pharmaceutical CDMO and Contract Manufacturing Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO and Contract Manufacturing Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO and Contract Manufacturing Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical CDMO and Contract Manufacturing Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CDMO and Contract Manufacturing Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CDMO and Contract Manufacturing Services Markets in 2022
Figure 27. United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type in 2022
Figure 31. Drug Development
Figure 32. API production
Figure 33. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2018-2029)
Figure 34. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application in 2022
Figure 36. Pharma Industry
Figure 37. Biotechnology
Figure 38. Others
Figure 39. Pharmaceutical CDMO and Contract Manufacturing Services Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO and Contract Manufacturing Services Players in 2022
Table 12. World Pharmaceutical CDMO and Contract Manufacturing Services Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO and Contract Manufacturing Services Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO and Contract Manufacturing Services Player
Table 15. Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO and Contract Manufacturing Services Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO and Contract Manufacturing Services Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO and Contract Manufacturing Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO and Contract Manufacturing Services Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2024-2029) & (USD Million)
Table 35. Haixiang Pharmaceutical Basic Information, Area Served and Competitors
Table 36. Haixiang Pharmaceutical Major Business
Table 37. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 38. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Haixiang Pharmaceutical Recent Developments/Updates
Table 40. Haixiang Pharmaceutical Competitive Strengths & Weaknesses
Table 41. Innovent Biologics Basic Information, Area Served and Competitors
Table 42. Innovent Biologics Major Business
Table 43. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 44. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Innovent Biologics Recent Developments/Updates
Table 46. Innovent Biologics Competitive Strengths & Weaknesses
Table 47. Betta Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Betta Pharmaceuticals Major Business
Table 49. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 50. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Betta Pharmaceuticals Recent Developments/Updates
Table 52. Betta Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Jiuzhou Pharmaceutical Basic Information, Area Served and Competitors
Table 54. Jiuzhou Pharmaceutical Major Business
Table 55. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 56. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Jiuzhou Pharmaceutical Recent Developments/Updates
Table 58. Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 59. Puluo Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Puluo Pharmaceutical Major Business
Table 61. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 62. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Puluo Pharmaceutical Recent Developments/Updates
Table 64. Puluo Pharmaceutical Competitive Strengths & Weaknesses
Table 65. Menohua Basic Information, Area Served and Competitors
Table 66. Menohua Major Business
Table 67. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 68. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Menohua Recent Developments/Updates
Table 70. Menohua Competitive Strengths & Weaknesses
Table 71. Tianyu shares Basic Information, Area Served and Competitors
Table 72. Tianyu shares Major Business
Table 73. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 74. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Tianyu shares Recent Developments/Updates
Table 76. Tianyu shares Competitive Strengths & Weaknesses
Table 77. Aoxiang Pharmaceutical Basic Information, Area Served and Competitors
Table 78. Aoxiang Pharmaceutical Major Business
Table 79. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 80. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Aoxiang Pharmaceutical Recent Developments/Updates
Table 82. Aoxiang Pharmaceutical Competitive Strengths & Weaknesses
Table 83. Hetero Basic Information, Area Served and Competitors
Table 84. Hetero Major Business
Table 85. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 86. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Hetero Recent Developments/Updates
Table 88. Hetero Competitive Strengths & Weaknesses
Table 89. CellMark Basic Information, Area Served and Competitors
Table 90. CellMark Major Business
Table 91. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 92. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CellMark Recent Developments/Updates
Table 94. CellMark Competitive Strengths & Weaknesses
Table 95. R&D Systems Basic Information, Area Served and Competitors
Table 96. R&D Systems Major Business
Table 97. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 98. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. R&D Systems Recent Developments/Updates
Table 100. R&D Systems Competitive Strengths & Weaknesses
Table 101. Porton Pharmaceuticals Basic Information, Area Served and Competitors
Table 102. Porton Pharmaceuticals Major Business
Table 103. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 104. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Porton Pharmaceuticals Recent Developments/Updates
Table 106. Porton Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. Kai Laiying Basic Information, Area Served and Competitors
Table 108. Kai Laiying Major Business
Table 109. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 110. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Kai Laiying Recent Developments/Updates
Table 112. Kai Laiying Competitive Strengths & Weaknesses
Table 113. Smart Life Basic Information, Area Served and Competitors
Table 114. Smart Life Major Business
Table 115. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 116. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Smart Life Recent Developments/Updates
Table 118. Smart Life Competitive Strengths & Weaknesses
Table 119. Notai Biotech Basic Information, Area Served and Competitors
Table 120. Notai Biotech Major Business
Table 121. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 122. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Notai Biotech Recent Developments/Updates
Table 124. Notai Biotech Competitive Strengths & Weaknesses
Table 125. Aurobindo Pharma Basic Information, Area Served and Competitors
Table 126. Aurobindo Pharma Major Business
Table 127. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 128. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 131. Lonza Group Basic Information, Area Served and Competitors
Table 132. Lonza Group Major Business
Table 133. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 134. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Lonza Group Recent Developments/Updates
Table 136. Lonza Group Competitive Strengths & Weaknesses
Table 137. Catalent Inc. Basic Information, Area Served and Competitors
Table 138. Catalent Inc. Major Business
Table 139. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 140. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Catalent Inc. Recent Developments/Updates
Table 142. Catalent Inc. Competitive Strengths & Weaknesses
Table 143. Recipharm AB Basic Information, Area Served and Competitors
Table 144. Recipharm AB Major Business
Table 145. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 146. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Recipharm AB Recent Developments/Updates
Table 148. Recipharm AB Competitive Strengths & Weaknesses
Table 149. Jubilant Pharmova Ltd Basic Information, Area Served and Competitors
Table 150. Jubilant Pharmova Ltd Major Business
Table 151. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 152. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Jubilant Pharmova Ltd Recent Developments/Updates
Table 154. Jubilant Pharmova Ltd Competitive Strengths & Weaknesses
Table 155. Patheon Inc. (Thermo Fisher Scientific Inc.) Basic Information, Area Served and Competitors
Table 156. Patheon Inc. (Thermo Fisher Scientific Inc.) Major Business
Table 157. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 158. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Developments/Updates
Table 160. Patheon Inc. (Thermo Fisher Scientific Inc.) Competitive Strengths & Weaknesses
Table 161. Boehringer Ingelheim Group Basic Information, Area Served and Competitors
Table 162. Boehringer Ingelheim Group Major Business
Table 163. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 164. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Boehringer Ingelheim Group Recent Developments/Updates
Table 166. Boehringer Ingelheim Group Competitive Strengths & Weaknesses
Table 167. Pfizer CentreSource Basic Information, Area Served and Competitors
Table 168. Pfizer CentreSource Major Business
Table 169. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 170. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Pfizer CentreSource Recent Developments/Updates
Table 172. Pfizer CentreSource Competitive Strengths & Weaknesses
Table 173. Baxter International Inc. Basic Information, Area Served and Competitors
Table 174. Baxter International Inc. Major Business
Table 175. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 176. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Baxter International Inc. Recent Developments/Updates
Table 178. Lonza Group Basic Information, Area Served and Competitors
Table 179. Lonza Group Major Business
Table 180. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product and Services
Table 181. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 182. Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services Upstream (Raw Materials)
Table 183. Pharmaceutical CDMO and Contract Manufacturing Services Typical Customers
LIST OF FIGURE
Figure 1. Pharmaceutical CDMO and Contract Manufacturing Services Picture
Figure 2. World Pharmaceutical CDMO and Contract Manufacturing Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO and Contract Manufacturing Services Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO and Contract Manufacturing Services Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO and Contract Manufacturing Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical CDMO and Contract Manufacturing Services by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CDMO and Contract Manufacturing Services Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CDMO and Contract Manufacturing Services Markets in 2022
Figure 27. United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical CDMO and Contract Manufacturing Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type in 2022
Figure 31. Drug Development
Figure 32. API production
Figure 33. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2018-2029)
Figure 34. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application in 2022
Figure 36. Pharma Industry
Figure 37. Biotechnology
Figure 38. Others
Figure 39. Pharmaceutical CDMO and Contract Manufacturing Services Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
